Paul Gama, Procter & Gamble CEO-health care, sells $698,460 in stock
Paul Gama, Procter & Gamble CEO-health care, sells $698,460 in stock Investing.com Canada
Covered in this story
Analyst targets on Procter & Gamble
- UBS: $159 → $172 by Oct 2027 · Buy via GuruFocus
- RBC Capital Markets: $148 → $166 by Oct 2027 via MarketBeat
- Evercore ISI: $150 → $166 by Oct 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PG yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Procter & Gamble →Dalsna Finance is currently tracking 42 stories mentioning Procter & Gamble, the earliest published 31 Aug 2026.
Summary aggregated from Investing.com Canada's public RSS feed. The full reporting belongs to Investing.com Canada — please read it on their site.